ML 786 dihydrochloride

Discontinued Product

ML 786 dihydrochloride (Cat. No. 5036) has been withdrawn from sale for commercial reasons.
Description: Potent Raf kinase inhibitor; orally bioavailable
Alternative Names: BGB659
Chemical Name: 3-(1-Amino-1-methylethyl)-N-[(2R)-1,2,3,4-tetrahydro-7-oxo-1,8-naphthryridin-4-yl)oxy]-2-naphthalenyl]-5-benzamide dihydrochloride
Purity: ≥98% (HPLC)
Citations (1)

Biological Activity for ML 786 dihydrochloride

Potent Raf kinase inhibitor (IC50 values are 2.1, 2.5 and 4.2 nM for B-RafV600E, C-Raf and wild-type B-Raf respectively). Also inhibits Abl-1, DDR2, EPHA2 and RET tyrosine kinase activity. Inhibits pERK formation and attenuates tumor growth in melanoma cell xenografts expressing the B-RafV600E mutation in vivo. Orally bioavailable.

Technical Data for ML 786 dihydrochloride

M. Wt 611.48
Formula C29H29F3N4O3.2HCl
Storage Store at +4°C
Purity ≥98% (HPLC)
CAS Number 1237536-18-3
PubChem ID 90488999
Smiles O=C(N[C@@H]2CCC(C=CC(OC4=C(CC5)C(NC=C4)=NC5=O)=C3)=C3C2)C1=CC(C(F)(F)F)=CC(C(N)(C)C)=C1.Cl.Cl

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for ML 786 dihydrochloride

References for ML 786 dihydrochloride

References are publications that support the biological activity of the product.

Gould et al (2011) Design and optimization of potent and orally bioavailable tetrahydronaphthalene Raf inhibitors. J.Med.Chem. 54 1836 PMID: 21341678

Sase et al (2018) Acquired JHDM1D-BRAF fusion confers resistance to FGFR inhibition in FGFR2-amplified gastric cancer. Mol.Cancer Ther. 17 2217 PMID: 30045926

View Related Products by Target

View Related Products by Product Action

View all Raf Kinase Inhibitors

Keywords: ML 786 dihydrochloride, ML 786 dihydrochloride supplier, ML786, dihydrochloride, potent, raf, kinase, inhibitors, inhibits, b-raf, c-raf, V600E, mutation, tyrosine, kinases, BGB659, Raf, Kinase, 5036, Tocris Bioscience

1 Citation for ML 786 dihydrochloride

Citations are publications that use Tocris products. Selected citations for ML 786 dihydrochloride include:

Sase et al (2018) Acquired JHDM1D-BRAF fusion confers resistance to FGFR inhibition in FGFR2- amplified gastric cancer. Mol.Cancer Ther. PMID: 30045926

Reviews for ML 786 dihydrochloride

There are currently no reviews for this product. Be the first to review ML 786 dihydrochloride and earn rewards!

Have you used ML 786 dihydrochloride?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review